RegisterLogin

Glecaprevir

CAT: 0804-HY-17634-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-17634-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Glecaprevir is a novel HCV NS3/4A protease inhibitor, with IC50 values ranging from 3.5 to 11.3 nM. Glecaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 4.09 μM[2].
CAS Number
[1365970-03-1]
Product Name Alternative
ABT-493
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
HCV; HCV Protease; SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Glecaprevir.html
Purity
99.93
Solubility
DMSO : ≥ 83.3 mg/mL
Smiles
O=C([C@H]1N(C([C@@H](NC(O[C@@]2([H])[C@@]3([H])CCC2)=O)C(C)(C)C)=O)C[C@@](OC4=NC5=CC=CC=C5N=C4C(F)(/C=C/CO3)F)([H])C1)N[C@]6([C@H](C(F)F)C6)C(NS(=O)(C7(CC7)C)=O)=O
Molecular Formula
C38H46F4N6O9S
Molecular Weight
838.87
Precautions
H302, H315, H319, H335
References & Citations
[1]Ng TI, et al. In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir. Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01620-17.|[2]Qi Sun, et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021 May 29;6 (1) :212.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched

Related Products

CatalogName

Alternative Products

CatalogName
BUP13076-01Glecaprevir
A16948-2Glecaprevir 2mg
A16948-50Glecaprevir 50mg
A16948-1Glecaprevir 1mg
A16948-10Glecaprevir 10mg
A16948-5Glecaprevir 5mg
A16948-25Glecaprevir 25mg
A16948-100Glecaprevir 100mg
TRC-G407016-10MGGlecaprevir-13C,D3
RM-G368001-01Glecaprevir Impurity 1

Popular Products